Research HUBS
Immunity and Inflammation
Membrane Communication and remodeling
Microbes in Health and Disease
Personalized Epigenomics
Pain Forum
Rare Diseases
Disorders of the Mind and Brain
Bioengineering Materials, Cells, and Tissues
Developmental Biology
Molecular Biology of Aging
Gene Therapy and Genome Editing
Immunity and Inflammation
Hub director: Lior Mayo
Lior’s Lab http://liormayolab.com
The Research Hub in Immunity and Inflammation aims to elucidate the mechanisms of inflammation and immune response underlying human disease and facilitate translating laboratory discoveries into new therapies.
Research areas:
- Immunology
- Autoimmunity
- Immuno-oncology
- Microbiome
- Infectious disease
- Neuro-immunology and neurodegenerative disease
- Host-pathogen interactions
- Drug development
- New antimicrobial strategies
- Immunotherapy
Membrane Communication and remodeling
Hub director: Ronit Sagi-Eisenberg
Intra and intercellular communication mediated by protein transport and membrane remodeling are essential processes for normal physiology, whose malfunctioning is linked with pathological pathways and disease.
Microbes in Health and Disease
Hub director: Elhanan Borenstein
Elhanan’s Lab http://www.borensteinlab.com
The Hub includes researchers from faculties across the university and TAU-affiliated hospitals, whose research involves microbiology, the microbiome, host/pathogen interactions and the effects and responses to antimicrobial drugs and compounds.
Research areas:
- Microbiology
- Bacteria
- Fungi
- Viruses
- Archea
- Infectious disease
- Microbiome
- Plant pathology
- Environment and ecology
- Community dynamics
- Host-pathogen interactions
- Antimicrobial drugs
- Drug development
- New antimicrobial strategies
- Evolution and drug resistance
Personalized Epigenomics
Hub director: Yuval Ebenstein
Lab https://www.nanobiophotonix.com
The BioMed @ TAU Research Hub in Personalized Epigenomics brings together the community of TAU researchers involved in exploring the epigenetic basis of normal development and disease. These investigators come from across the TAU faculties and affiliated hospitals and share an interest in the processes that alter gene activity without changing the DNA sequence. This rapidly growing field encompasses research into such areas as embryonic development, plant biology, neurodegenerative disease and cancer.
Pain Forum
Hub directors: Ruth Defrin and Silviu Brill
Requested photo: https://www.shutterstock.com/image-illustration/3d-illustration-neck-painful-cervical-spine-1029546799
Pain is major cause of suffering. Our mission is to brings together people who study or who are interested in studying pain and pain-related topics including scientists, clinicians, and students.
Our goals are to increase awareness to the problem of pain, to stimulate exchange of ideas, to encourage collaborations between hub members and mutual grant submissions and to inspire state of the art basic science and clinical studies on pain mechanisms, pain measurement, pain management and rehabilitation.
Rare Diseases
Hub directors: Miguel Weil and Annick Rothschild
About Rare Diseases
An estimated 6% of the population is afflicted with a rare disease, a number comprised of predominately children (80%). This means that in Israel alone, rare diseases may affect around half a million people and impact the lives of many more, including parents and siblings. The health of these individuals and their families is a major societal challenge for Israel, and it requires the development of personalized adapted medicines and treatment strategies. For this reason, we formed the Research Hub in Rare Diseases at Tel Aviv University in collaboration with the Sheba Medical Center’s Institute of Rare Diseases to address the challenges linked to the care of these patients and their families.
Goals:
With a strong network of researchers, clinicians and other partners, the Research Hub in Rare Diseases has the potential to target user communities (including industry partners) and policymakers and thus better empower patients and parents. Specific goals include:
- Create new networks by stimulating more collaboration between clinicians, basic researchers, education specialists, public health specialists, computer scientists and other partners
- Combine resources and expertise to conduct and manage robust studies, develop new treatments, and raise awareness to build these networks
Research Areas:
- Biomedical research in rare diseases
- Clinical work in rare diseases
- Cell biology
- Animal model systems
- Biomedical devices
- Metabolism
- Bioinformatics
- Public health
- Big Data
- Patient information policies
- Legislation
Disorders of the Mind and Brain
Hub directors: Boaz Barak and Avi Ashkenazi
Labs https://socsci3.tau.ac.il/boazbarak/ https://www.ashkenazilab.com
The BioMed@TAU Research Hub Disorders of the Mind and Brain is focused on understanding the pathophysiological mechanisms of disorders involved in the brain and mind and ways to better diagnose and treat such disorders.
Bioengineering Materials, Cells, and Tissues
Hub directors: Ben Maoz and Lihi Adler-Abramovich
Labs https://www.maozlab.com https://lihi13.wixsite.com/lihi
The BioMed @ TAU Research Hub Bioengineering Materials, Cells and Tissues brings together the community of people at TAU working with these components. The Hub includes researchers from faculties across the university and TAU-affiliated hospitals interested in engineering and developing materials, cells, and tissues.
Developmental Biology
Hub directors: Ruth Ashery-Padan, Limor Landsman, and Chen Luxenberg
Labs http://asherypadan.medicine.mytau.org https://www.landsman-lab.com https://www.luxenburglab.com
Developmental Biology and Stem Cell Research- Molecular and cellular processes controlling tissue differentiation and organ development during embryo development and the relevance of disease.
Molecular Biology of Aging
Hub director: Danny Barr
Gene Therapy and Genome Editing
Hub director: Adi Barzel
